Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Steba Biotech S.A.

By efain on Tue, 01/12/2021 - 13:45
  • Read more about Steba Biotech S.A.

ADC Therapeutics

By efain on Tue, 01/12/2021 - 12:33
  • Read more about ADC Therapeutics

IO Biotech ApS

By efain on Wed, 01/06/2021 - 16:13
  • Read more about IO Biotech ApS

Gannex Pharma Co., Ltd.

By efain on Wed, 01/06/2021 - 16:08
  • Read more about Gannex Pharma Co., Ltd.

Avelas Biosciences, Inc.

By efain on Tue, 12/15/2020 - 14:26
  • Read more about Avelas Biosciences, Inc.

Cook MyoSite, Incorporated

By efain on Mon, 12/07/2020 - 17:00
  • Read more about Cook MyoSite, Incorporated
Expanded Access Listings

Expanded Access Program for Autologous Muscle Derived Cells (AMDCs)

This is an expanded access program (EAP) for eligible participants designed to provideaccess to autologous muscle derived cells (AMDCs). Treating physicians may submitrequests for expanded access to Cook MyoSite's investigational product by email toMYO-ExpandedAccess@CookMyoSite.com.

Oscillation and Lung Expansion Therapy in Patients With COVID-19

  • Read more about Oscillation and Lung Expansion Therapy in Patients With COVID-19

Patients Reactions Towards Their Diagnosis as Having COVID-19

  • Read more about Patients Reactions Towards Their Diagnosis as Having COVID-19

Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2)

  • Read more about Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2)

Inflammatory Signal Inhibitors for COVID-19 (MATIS)

  • Read more about Inflammatory Signal Inhibitors for COVID-19 (MATIS)

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 240
  • Page 241
  • Page 242
  • Page 243
  • Current page 244
  • Page 245
  • Page 246
  • Page 247
  • Page 248
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA